Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX2ATX
|
||||
Drug Name |
4-azido-N-(2-(2-(4-(4-chloro-2-fluorophenylamino)-6-methoxyquinazolin-7-yloxy)ethoxy)ethyl)-2,3,5,6-tetrafluorobenzamide
|
||||
Synonyms |
CHEMBL199573
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C26H19ClF5N7O4
|
||||
Canonical SMILES |
COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCOCCNC(=O)c4c(F)c(F)c(N=[N+]=[N-])c(F)c4F
|
||||
InChI |
InChI=1S/C26H19ClF5N7O4/c1-41-17-9-13-16(35-11-36-25(13)37-15-3-2-12(27)8-14(15)28)10-18(17)43-7-6-42-5-4-34-26(40)19-20(29)22(31)24(38-39-33)23(32)21(19)30/h2-3,8-11H,4-7H2,1H3,(H,34,40)(H,35,36,37)
|
||||
InChIKey |
SPKLCZINGKURTD-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
Vascular endothelial growth factor receptor 1 | Target Info | [1587926] | |||
KEGG Pathway | Ras signaling pathway | ||||
Rap1 signaling pathway | |||||
Cytokine-cytokine receptor interaction | |||||
Endocytosis | |||||
PI3K-Akt signaling pathway | |||||
VEGF signaling pathway | |||||
Focal adhesion | |||||
Proteoglycans in cancerhsa04014:Ras signaling pathway | |||||
HIF-1 signaling pathway | |||||
Transcriptional misregulation in cancer | |||||
Rheumatoid arthritis | |||||
NetPath Pathway | IL2 Signaling Pathway | ||||
PANTHER Pathway | Angiogenesis | ||||
VEGF signaling pathway | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
Beta3 integrin cell surface interactions | |||||
Signaling events mediated by TCPTP | |||||
SHP2 signaling | |||||
S1P1 pathway | |||||
VEGF and VEGFR signaling network | |||||
Integrins in angiogenesis | |||||
Signaling events mediated by VEGFR1 and VEGFR2 | |||||
Notch-mediated HES/HEY networkglypican_1pathway:Glypican 1 network | |||||
S1P3 pathway | |||||
VEGFR1 specific signals | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.